Orbimed Asia III Mauritius submits disclosure

18 Mar 2019 Evaluate

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Orbimed Asia III Mauritius.

The above information is a part of company’s filings submitted to BSE.

Advanced Enzyme Share Price

358.25 4.10 (1.16%)
03-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1849.10
Dr. Reddys Lab 1352.75
Cipla 1510.25
Lupin 2367.85
Zydus Lifesciences 975.55
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.